Hereditary cancer genetic testing helps identify high-risk patients.1,2 Invitae makes it easy.
Early detection of a hereditary cancer genetic variant can make a difference
High-risk genetic variants are associated with more biologically aggressive prostate cancer.1,6 Early detection may give your patients a better chance at improved outcomes.1,5 In metastatic cases, survival among men with a BRCA1 or BRCA2 variant is half that of men with no genetic variant.7
Hereditary prostate cancer genetic testing helps you know when to wait and when to act
Prostate cancer genetic testing can reveal a patient's potential risk of more aggressive disease to help inform next steps.1
Prioritize patients for biopsy6,8
Validate patient PSA results5,8
Place patients on active surveillance4
Flag patients who need more immediate intervention, including surgery, radiation or clinical trials1,6,9
Family history is not enough—by testing everyone, you overlook no one
Many patients with prostate cancer who have genetic variants have no suggestive family history.1 In fact, as many as 70% of men with advanced or metastatic prostate cancer who had an actionable pathogenic hereditary cancer variant didn’t qualify for genetic testing based on family history.10
Testing beyond prostate cancer guidelines may help identify patients with high-risk variants that may otherwise go undetected.1